Efficace, Fabio
Cottone, Francesco
Oswald, Laura B.
Cella, David
Patriarca, Andrea
Niscola, Pasquale
Breccia, Massimo
Platzbecker, Uwe
Palumbo, Giuseppe A.
Caocci, Giovanni
Stauder, Reinhard
Ricco, Alessandra
Petranovic, Duska
Caers, Jo
Luppi, Mario
Fianchi, Luana
Frairia, Chiara
Capodanno, Isabella
Follini, Elena
Sarlo, Chiara
Fazi, Paola
Vignetti, Marco
Article History
Received: 22 November 2019
Revised: 31 January 2020
Accepted: 5 February 2020
First Online: 21 February 2020
Compliance with ethical standards
:
: FE: Consultancy: Bristol-Myers Squibb, Amgen, Orsenix, Incyte, Takeda; Research funding to his insitution: Amgen. DC: President, FACIT.org. AP: Advisory board: Sanofi, Amgen, Novartis. GAP: Honoraria: Jannsen, Novartis, Celgene. ML: Consultancy: Abbvie, Gilead Sci, Novartis, Daiichi Sankyo, MSD, Sanofi; Honoraria for speaking: Gilead Sci, Novartis. MB: Honoraria: Novartis, Pfizer, Incyte, Celgene. RS: Honoraria, Membership on an entity’s Board of Directors or advisory committees: Novartis, Celgene; Research funding: Teva. UP: Research funding and Honoraria: Celgene, Amgen, Janssen, Novartis. MV: personal fees: Pfizer, Amgen, Novartis. DP: received support for active participation on congresses from Roche and Sanofi Genzyme.